TB Research

Host factors associated with false negative results in an interferon‐γ release assay in adults with active tuberculosis:a single-center retrospective study

Quan-Xian Liu, Jian‐Qing He

Abstract

<b>Objective:</b> To identify host factors associated with false-negative results of interferon-γ release tests in adults with active tuberculosis. <b>Methods:</b> The clinical data of 909 patients with active tuberculosis diagnosed by acid-fast smear staining, Mycobacterium tuberculosis culture, mycobacterium tuberculosis PCR and pathological examination at West China Hospital of Sichuan University were retrospectively analyzed. They were divided into the IGRA<sup>-</sup> group and IGRA<sup>+</sup> group. Logistic regression was used to analyze the sociodemographic data and clinical characteristics of participants in the IGRA<sup>-</sup>group and IGRA<sup>+</sup> group. <b>Results:</b> Among 909 patients with active tuberculosis, 169 (18.6%) were IGRA negative (false negative), and 740 (81.4%) were IGRA positive. Multivariate logistic regression analysis identified the following characteristics independently associated with IGRA negativity: older age (OR: 1.02; 95% CI: 1.01 1.03; p =0.003), anti-tuberculosis treatment &gt; 1 month (OR: 0.66; 95% CI: 0.44 0.99; p =0.042), HIV infection (OR: 0.07; 95% CI: 0.02 0.25; p = 0.000), combined with connective tissue diseases (OR: 0.34; 95% CI: 0.16 0.73; p =0.005) and low hemoglobin (OR: 0.99; 95% CI: 0.98 1.00; p =0.009) was associated with an increased false-negative probability of IGRA. <b>Conclusion:</b> Older age, anti-tuberculosis therapy &gt; 1 month, coinfection with HIV, coassociated connective tissue disease and decreased hemoglobin were identified as risk factors for false-negative results of false IGRA. Our results suggest a careful interpretation of IGRA in adults with these characteristics.

MeSH terms

  • Tuberculosis
  • Internal medicine
  • Mycobacterium tuberculosis
  • Medicine
  • Coinfection
  • Logistic regression
  • Gastroenterology
  • Retrospective cohort study
  • Immunology